TY  - JOUR

T1  - Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31

JO  - Journal of Clinical Oncology

PY  - 2015/03/16

AU  - Gelmon KA

AU  - Boyle FM

AU  - Kaufman B

AU  - Huntsman DG

AU  - Manikhas A

AU  - Di Leo A

AU  - Martin M

AU  - Schwartzberg LS

AU  - Lemieux J

AU  - Aparicio S

AU  - Shepherd LE et al

ED  - 

DO  - DOI: 10.1200/jco.2014.56.9590

PB  - American Society of Clinical Oncology (ASCO)

VL  - 33

IS  - 14

SP  - 1574

EP  - 1583

Y2  - 2025/10/10

ER  -